The Combination of Ophthalmologic Tests and EEG Imaging as a New Biomarker for Alzheimer's Disease
The Combination of Ophthalmologic Tests and EEG Imaging as a New Biomarker for Alzheimer's Disease
Alzheimer's disease (AD) is a prevalent, long-term progressive degenerative disorder with great social impact. It is currently thought that, in addition to neurodegeneration, vascular changes also play a role in the pathophysiology of the disease. Meantime, EEG resting state has also demonstrated significant change in patients with AD in neuroscience research area. Thus, the combination of these sensitive biomarkers would lead to a potential new biomarker for detection of AD, which has higher specificity and sensitivity.
Inclusion Criteria:
Exclusion Criteria:
yuanjincornea@126.com13825141659
guli7@mail2.sysu.edu.cn+8615889937313